
1. cell. 2014 dec 4;159(6):1277-89. doi: 10.1016/j.cell.2014.10.053.

gut microbiota elicits protective immune response malaria transmission.

yilmaz b(1), portugal s(2), tran tm(2), gozzelino r(1), ramos s(1), gomes j(3),
regalado a(1), cowan pj(4), d'apice aj(4), chong as(5), doumbo ok(6), traore
b(6), crompton pd(2), silveira h(7), soares mp(8).

author information: 
(1)instituto gulbenkian de ciência, rua da quinta grande, 6, 2780-156 oeiras,
portugal.
(2)laboratory immunogenetics, national institute allergy infectious
diseases, national institutes health, twinbrook ii, room 125, 12441 parklawn
drive, rockville, md 20852-8180, usa.
(3)instituto gulbenkian de ciência, rua da quinta grande, 6, 2780-156 oeiras,
portugal; centro de malaria e outras doenças tropicais, instituto de higiene e
medicina tropical, universidade nova de lisboa, rua da junqueira, 100, 1349-008
lisboa, portugal.
(4)immunology research centre, st. vincent's hospital, fitzroy, melbourne, vic
3065, australia; department medicine, university melbourne, parkville, vic 
2900, australia.
(5)section transplantation, department surgery, university chicago, 5841
south maryland avenue, chicago, il 60637, usa.
(6)mali international center excellence research, university sciences,
techniques technologies bamako, 1805 bamako, mali.
(7)centro de malaria e outras doenças tropicais, instituto de higiene e medicina 
tropical, universidade nova de lisboa, rua da junqueira, 100, 1349-008 lisboa,
portugal.
(8)instituto gulbenkian de ciência, rua da quinta grande, 6, 2780-156 oeiras,
portugal. electronic address: mpsoares@igc.gulbenkian.pt.

comment in
    trends parasitol. 2015 jan;31(1):2-4.
    nat rev immunol. 2015 jan;15(1):1.

glycosylation processes high natural selection pressure, presumably
because modulate resistance infection. here, asked whether
inactivation udp-galactose:β-galactoside-α1-3-galactosyltransferase
(α1,3gt) gene, ablated expression galα1-3galβ1-4glcnac-r (α-gal)
glycan allowed production anti-α-gal antibodies (abs) humans,
confers protection plasmodium spp. infection, causative agent of
malaria major driving force human evolution. demonstrate both
plasmodium spp. human gut pathobiont e. coli o86:b7 express α-gal and
that anti-α-gal abs associated protection malaria transmission
in humans well α1,3gt-deficient mice, produce protective
anti-α-gal abs colonized e. coli o86:b7. anti-α-gal abs target plasmodium
sporozoites complement-mediated cytotoxicity skin, immediately after
inoculation anopheles mosquitoes. vaccination α-gal confers sterile
protection malaria mice, suggesting similar approach may reduce
malaria transmission humans.

copyright © 2014 authors. published elsevier inc. rights reserved.

doi: 10.1016/j.cell.2014.10.053 
pmcid: pmc4261137
pmid: 25480293  [indexed medline]

